James Cassella
Director/Board Member at TREVI THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
James Cassella active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-02-03 | - |
| TREVI THERAPEUTICS, INC. | Director/Board Member | 2020-02-12 | - |
| Independent Dir/Board Member | 2020-02-12 | - |
Career history of James Cassella
Former positions of James Cassella
| Companies | Position | Start | End |
|---|---|---|---|
| ALEXZA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2004-05-31 | 2015-01-28 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Corporate Officer/Principal | 1989-03-31 | 2004-05-31 |
| Oberlin College | Corporate Officer/Principal | - | - |
Training of James Cassella
| Dartmouth College | Doctorate Degree |
| University of New Haven | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- James Cassella
- Experience
